Aldesleukin Recruiting Phase 1 Trials for Ulcerative Colitis Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02200445Low Dose IL-2 for Ulcerative Colitis